IQ Therapeutics has developed a proprietary technology for the generation of fully human antibodies from the blood of vaccinated or immunized donors. It is IQ’s philosophy that the most physiological origin for antibodies to be applied as therapeutic agent inside a human body is the human body itself. The human immune response is the basis for IQ’s technology and therefore labeled "Cloning the Human Response". The aim is to apply this technology for the generation of protective antibodies which can serve as passive immunization to protect humans against e.g. infectious diseases and cancer, thus providing "instant immunity".
Thursday, 23 February 2012
Subscribe to our RSS Feed 